Iotrolan

DB09487ApprovedWithdrawnSmall molecule

Nonionic, isotonic contrast medium designed for intrathecal use.

Chemical structure of Iotrolan
Formula / weight
C37H48I6N6O18 · 1626.242 g/mol (avg)
First approval
Canada, 2007
Code names
DL 3-117 · ZK-39-482

Resolves to

Compound
UNII16FL47B687CAS79770-24-4ChEMBLCHEMBL1200555ChEBI31715KEGGD01714
Clinical / RWD
RxNorm51474ATCV08AB06
Structure
InChIKeyXUHXFSYUBXNTHU-UHFFFAOYSA-NSMILESCN(C(=O)CC(=O)N(C)C1=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C1I)C1=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C1I

What you can answer from here — as of March 06, 2025

2Marketed productsAcross 1 country and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 9 drug categories
Sign in

Which companies are running trials of Iotrolan, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In